ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Panel Resumes Deliberations

January 4, 1980

Resource Offered for DNA Probe Mapping

August 14, 1987

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993